| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
|
| | Ponezumab Basic information |
| Product Name: | Ponezumab | | Synonyms: | Ponezumab;Anti-Human APP(Ponezumab);Research Grade Ponezumab(DHK08301);Research Grade Ponezumab;Ponezumab (anti-Amyloid Beta) | | CAS: | 1178862-65-1 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Ponezumab Structure]() |
| | Ponezumab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Ponezumab Usage And Synthesis |
| Uses | Ponezumab (PF-04360365) is a humanised anti-amyloid IgG2 monoclonal antibody. Ponezumab reduces Aβ levels in the central nervous system and improves performance in mice in various models of learning and memory. Ponezumab can be used in study of Alzheimer's disease[1]. | | References | [1] Nicholas T, et al. Preliminary population pharmacokinetic modeling of PF-04360365, a humanized anti-amyloid monoclonal antibody, in patients with mild-to-moderate Alzheimer's disease[J]. Alzheimer's and Dementia, 2009, 5(4): P253. |
| | Ponezumab Preparation Products And Raw materials |
|